McMahon, who founded the company after his daughter was diagnosed with Type 1 diabetes, has discovered that the medical community places most of the responsibility for care with patients and often doesn’t take into account the need for other support. “That is the number one thing: You don’t manage it by yourself,” McMahon said. He added that traditionally, the driving force behind new technology has been reimbursement—either government or private—rather than patient needs. With the firsthand perspective of a family affected by diabetes, McMahon developed the GlucoMON as a means of promoting compliance.